Holen Sie sich die Stockscreener-App
1.18
9.23%
-0.12
Handel nachbörslich:
1.19
0.01
+0.85%
Schlusskurs vom Vortag:
$1.30
Offen:
$1.32
24-Stunden-Volumen:
293.67K
Relative Volume:
2.64
Marktkapitalisierung:
$19.81M
Einnahmen:
$48.43M
Nettoeinkommen (Verlust:
$-11.04M
KGV:
-1.7612
EPS:
-0.67
Netto-Cashflow:
$-7.00M
1W Leistung:
-9.23%
1M Leistung:
+16.83%
6M Leistung:
-21.85%
1J Leistung:
-40.10%
1-Tages-Spanne:
$1.17
$1.3353
1-Wochen-Bereich:
$1.17
$1.3353
52-Wochen-Spanne:
$0.782
$2.14
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Vergleichen Sie IRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.18 | 21.83M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
IRIDEX Corporation (NASDAQ:IRIX) Q2 2025 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost Challenges - uk.finance.yahoo.com
Iridex Reports 7 Percent Q2 Revenue Gain - The Motley Fool
Earnings call transcript: IRIDEX beats Q2 2025 EPS and revenue estimates - Investing.com
Iridex: Q2 Earnings Snapshot - San Antonio Express-News
IRIDEX earnings beat by $0.03, revenue topped estimates - Investing.com
Iridex Reports Second Quarter 2025 Financial Results - Yahoo Finance
Risk vs reward if holding onto IRIDEX CorporationMachine Learning Stock Price Forecast Tool - Newser
Chart based analysis of IRIDEX Corporation trendsPredictable Return Strategy with AI Support - Newser
What does recent volatility data suggest for IRIDEX CorporationFree Momentum Based Equity Trading Plan - Newser
Comparing IRIDEX Corporation in custom built stock radarsBreakout Monitoring with Momentum Analysis - Newser
Why IRIDEX Corporation stock attracts strong analyst attentionTrading Watchlist with Real Time Filters - Newser
Has IRIDEX Corporation found a price floorFree Conservative Long Term Growth Plans - Newser
Is This a Bottoming Phase for IRIDEX CorporationCommunity Strategy With High Win Rate Backtested - beatles.ru
What are analysts’ price targets for IRIDEX Corporation in the next 12 monthsBreakthrough wealth creation - Jammu Links News
What is the risk reward ratio of investing in IRIDEX Corporation stockMarket-leading profit generation - Jammu Links News
IRIDEX Corporation Stock Approaches Key Moving AverageCommunity Shared Smart Money Signals Show Movement - beatles.ru
Is IRIDEX Corporation a growth stock or a value stockExpert Picks Outlook To Watch Now - Jammu Links News
Is IRIDEX Corporation showing signs of accumulationCapital Growth Summary Over Five Years - Newser
Analyzing IRIDEX Corporation with multi timeframe chartsFree Earnings Play Trade Plan With Alerts - Newser
When is the best time to buy IRIDEX Corporation stockFree Weekly Stock Watch With Growth Focus - Newser
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times
Will IRIDEX Corporation stock go up soonShort-Term Upside Breakout Forecast System - Newser
How IRIDEX Corporation stock performs during market volatilityFree Market Entry and Exit Point Tips - Newser
Iridex Corporation to Announce Q2 2025 Financial Results and Business Update on August 12, 2025 - Quiver Quantitative
Medical Laser Leader Iridex Announces Q2 2025 Earnings Call Details - Stock Titan
RSI Suggests Rebound May Be Near in IRIDEX CorporationReal-Time Analysis With Entry Targets In Progress - beatles.ru
Tools to assess IRIDEX Corporation’s risk profileFuture Growth Stock Forecasting Strategy - Newser
Sentiment Tools Show Shift in Trader Mood on IRIDEX CorporationFast Entry High Potential Stock Alerts Triggered - metal.it
What is the dividend policy of IRIDEX Corporation stockCapitalize on fast-growing investment opportunities - Jammu Links News
Does IRIDEX Corporation stock perform well during market downturnsRemarkable growth - Jammu Links News
What institutional investors are buying IRIDEX Corporation stockAccess high-yield investment alerts now - Jammu Links News
Intrinsic Value of IRIDEX Corporation Stock: Is It Undervalued or OvervaluedFree Real-Time Stock Data - Newser
What analysts say about IRIDEX Corporation stockAccelerated earnings growth - PrintWeekIndia
What drives IRIDEX Corporation stock priceRobust financial gains - PrintWeekIndia
What drives TBPH stock pricePhenomenal capital appreciation - Autocar Professional
IRIDEX Corporation Stock Analysis and ForecastConsistent high-yield stocks - Autocar Professional
Retinal Detachment Market Set for Steady Expansion by 2032, - openPR.com
Is IRIDEX Corporation a good long term investmentExceptional growth trajectory - Autocar Professional
What makes IRIDEX Corporation stock price move sharplyTop Performing Low Risk Stocks - Newser
What caused IRIX's earnings surprises in 2024? - AInvest
Iridex corp director William Moore acquires $19,372 in stock By Investing.com - Investing.com South Africa
Iridex corp director William Moore acquires $19,372 in stock - Investing.com
Iridex corp CEO Patrick Mercer buys $240 in common stock By Investing.com - Investing.com Canada
Iridex corp CEO Patrick Mercer buys $240 in common stock - Investing.com Australia
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):